---
title: "BRONSTEIN BEN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0d26ddbb-c3bb-528a-8d39-c6d6a9788d47
json: https://whiteintel.dev/api/public/dossier/0d26ddbb-c3bb-528a-8d39-c6d6a9788d47
identifier: sec:0001604458
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# BRONSTEIN BEN

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001604458`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0d26ddbb-c3bb-528a-8d39-c6d6a9788d47  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0d26ddbb-c3bb-528a-8d39-c6d6a9788d47  

## Ownership & control

### Holdings / subsidiaries

- **Aldeyra Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/23de0706-f8b0-5c27-8fa0-0a735bff0355

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BRONSTEIN BEN**. Human view: https://whiteintel.dev/entity/0d26ddbb-c3bb-528a-8d39-c6d6a9788d47 · Structured JSON: https://whiteintel.dev/api/public/dossier/0d26ddbb-c3bb-528a-8d39-c6d6a9788d47._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._